Medpace Holdings (MEDP) Operating Expenses (2015 - 2026)

Medpace Holdings (MEDP) has reported Operating Expenses for 12 consecutive years, with $560.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Operating Expenses rose 17.51% year-over-year to $560.5 million; the trailing twelve-month figure through Jun 2026 stood at $2.2 billion (up 25.34% YoY), and the FY2025 full-year result was $2.0 billion, up 20.04% from the prior year.
• Operating Expenses declined to $560.5 million in Q2 2026 per MEDP's latest filing, from $565.1 million in the prior quarter.
• Across five years, Operating Expenses topped out at $565.1 million in Q1 2026 and bottomed at $266.7 million in Q1 2022.
• Historically, Operating Expenses has averaged $417.4 million across 5 years, with a median of $411.1 million in 2023.
• The sharpest annual moves came in 2024 and 2025: Operating Expenses advanced 0.03% in 2024, then surged 35.01% in 2025.
• Over 5 years, Operating Expenses stood at $317.7 million in 2022, then rose by 29.41% to $411.1 million in 2023, then increased by 0.03% to $411.2 million in 2024, then jumped by 35.01% to $555.2 million in 2025, then climbed by 0.96% to $560.5 million in 2026.
• According to Business Quant data, Operating Expenses over the past three periods registered $560.5 million, $565.1 million, and $555.2 million for Q2 2026, Q1 2026, and Q4 2025 respectively.